DiscoverBlunt Business
Blunt Business
Claim Ownership

Blunt Business

Author: Cannabis Radio

Subscribed: 142Played: 4,306
Share

Description

Dispensing Cannabis business knowledge beyond a million square feet of cultivation space. Blunt Business navigates the challenges and opportunities of one of the most profitable industries on earth. Join us each episode to hear our weekly round tables and interviews with industry professionals.

494 Episodes
Reverse
As daily cannabis use climbs to roughly 1.2 million people in Great Britain (Forbes), retail pharmacy giant Boots is launching its SureLeaf online prescription service across roughly 1,800 UK locations to offer affordable medical cannabis flower and oil starting at £40—a mainstream breakthrough modeled directly on clinical pharmacy integration (MJBizDaily; The Telegraph). This rollout mirrors the clinical blueprint pioneered in Utah, where state law replaces traditional retail "budtenders" with licensed Pharmacy Medical Providers (PMPs) who review patient medical histories, screen for CYP-mediated drug interactions, and guide individualized dose titration (Pharmacy Times; Cannabis Industry Journal). Together, Utah's established framework and the UK's high-street expansion validate a crucial lesson underscored by pharmacy policy experts (Pharmacy Times): embedding licensed pharmacists into regulated cannabis distribution—rather than sidelining them as Canada did (Pharmacy Times)—legitimizes the plant as a safe, standardized therapeutic, protects vulnerable patients, and unlocks sustainable mainstream market growth.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Blunt Business welcomes back Kevin Koby, CEO and co-founder of Abstrax Tech. Returning to the show five and a half years after his first appearance, Koby discusses his transition from Chief Scientific Officer to CEO and highlights how Abstrax Tech has evolved from a terpene distributor to an industry leader in aroma chemistry and analytical research.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Blunt Business speaks with Jonathan Wachs regarding the DEA’s proposed Schedule 3 rescheduling process, the launching of the Form 225 registration portal for medical cannabis operators, and the regulatory and compliance challenges facing businesses in dual-use markets.The Drug Enforcement Administration (DEA) has launched its Schedule 3 registration portal using Form 225 for medical cannabis manufacturers, distributors, and analytical laboratories. Applying through the system involves substantial non-refundable annual registration fees, set at $3,699 for manufacturers, $1,850 for distributors, and $296 for analytical labs. Given the complexity of the disclosures required on Form 225, Wachs advises operators to retain legal counsel to ensure accurate filings and navigate potential legal exposures.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Driven by consumers seeking hangover-free buzzes, the rapid surge in hemp-derived THC beverages has triggered a high-stakes civil war across the US alcohol landscape. Traditional brewers and distillers—reeling from a historic downturn in conventional booze sales—are aggressively lobbying for strict regulatory caps as low as 0.4 mg of THC per beverage to shut down competition, while liquor distributors and retailers fight to protect a booming category that generates over $1 billion annually and threatens to slice up to 20% off their bottom lines if outlawed. As mainstream liquor store shelves increasingly swap out craft beer and spirits for rapid-acting seltzers, alcohol heavyweights find themselves sharply divided: some push to force all cannabinoid drinks behind dispensary counters, while conglomerates like Tilray lean into the disruption by producing both craft beer and THC cocktails to meet evolving consumer tastes.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
True Terpenes CEO Daniel Cook joins Blunt Business to discuss the company's innovative "Loud Flavors" platform, designed to provide accessible, nostalgia-driven entry points for new cannabis consumers. We explore rigorous toxicology compliance, co-funded university research at Johns Hopkins and UCLA, data-driven market insights across legal states, and the evolving business implications of federal cannabis rescheduling.1Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
loading
Comments